(Q71688994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

J A Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A J Slater

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

I R Campbell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

V Kelly

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

155-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01806182

20 October 2019

exact match

0 references

cites work

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

12 December 2020

Dose-response in the treatment of breast cancer: a critical review

1 reference

12 December 2020

Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer.

1 reference

12 December 2020

A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer

1 reference

12 December 2020

A comparison of mitoxantrone and doxorubicin in breast cancer.

1 reference

12 December 2020

Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantrone

1 reference

12 December 2020

Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy

1 reference

12 December 2020

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

12 December 2020

Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial

1 reference

12 December 2020

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancer

1 reference

12 December 2020

High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer

1 reference

12 December 2020

Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast

1 reference

12 December 2020

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1 reference

12 December 2020

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

1 reference

12 December 2020

Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.

1 reference

12 December 2020

Mitoxantrone: an overview of safety and toxicity

1 reference

12 December 2020

New cytotoxic drugs in treatment of breast cancer

1 reference

12 December 2020

First-line mitoxantrone chemotherapy for advanced breast cancer

1 reference

12 December 2020

Breast cancer: chemotherapy in the treatment of advanced disease

1 reference

12 December 2020

Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8872324%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference